Study of Fluoxetine in Autism
Public ClinicalTrials.gov record NCT00515320. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Study Of Fluoxetine In Autism: A Randomised, Double-Blind, Placebo-Controlled, Parallel-Group 14-Week Study To Investigate The Effect Of Fluoxetine Orally Dissolving Tablet (ODT) On Repetitive Behaviors In Childhood And Adolescent Autistic Disorder.
Study identification
- NCT ID
- NCT00515320
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Lead sponsor
- Neuropharm
- Industry
- Enrollment
- 158 participants
Conditions and interventions
Conditions
Interventions
- Fluoxetine Drug
- Placebo Drug
Drug
Eligibility (public fields only)
- Age range
- 5 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jul 31, 2007
- Primary completion
- Dec 31, 2008
- Completion
- Dec 31, 2008
- Last update posted
- Apr 26, 2012
2007 – 2009
United States locations
- U.S. sites
- 17
- U.S. states
- 15
- U.S. cities
- 17
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Southwest Autism Research and Resource Centre | Phoenix | Arizona | 85006 | — |
| University of California Davis | Sacramento | California | 95817 | — |
| University of Florida, Department of Psychiatry | Gainesville | Florida | 32611 | — |
| Institute for Behavioral Medicine | Smyrna | Georgia | 30080 | — |
| University of Illinois | Chicago | Illinois | 60637-1448 | — |
| AMR-Baber Research Inc. | Naperville | Illinois | 60563 | — |
| Harvard Medical School | Medford | Massachusetts | 02155 | — |
| Children's Hospital of Michigan | Detroit | Michigan | 48201 | — |
| Center for Psychiatry and Behavioral Medicine | Las Vegas | Nevada | 89128 | — |
| CRCNJ | Voorhees Township | New Jersey | 08043 | — |
| Long Island Jewish Hospital | Bethpage | New York | 11714 | — |
| Mount Sinai School of Medicine | New York | New York | 10029 | — |
| University of North Carolina | Chapel Hill | North Carolina | 27514 | — |
| Ohio State University | Columbus | Ohio | 43210 | — |
| Western Psychiatric Institute and Clinic/ Merck Child Outpatient Clinic | Pittsburgh | Pennsylvania | 15203 | — |
| Red Oak Psychiatry Associates | Houston | Texas | 77090 | — |
| Seattle Children's Hosptial University of Washington | Seattle | Washington | 98105-0371 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00515320, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Apr 26, 2012 · Synced May 10, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT00515320 live on ClinicalTrials.gov.